ARTICLE | Clinical News
Lamisil terbinafine hydrochloride regulatory update
October 8, 2007 7:00 AM UTC
FDA approved an oral granule formulation of Lamisil terbinafine to treat tinea capitis (ringword of the scalp) in children aged 4 and up. NVS already markets the synthetic allylamine antifungal to tre...